Perrigo Confirms Patent Challenge For Generic Version Of Kerydin(R)

DUBLIN, Oct. 29, 2018 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that Anacor Pharmaceuticals, Inc., initiated patent litigation on October 25, 2018 in the United States District Court for the Distri... Biopharmaceuticals, Generics, Litigation Perrigo, Anacor Pharmaceuticals, tavaborole, Kerydin, onychomycosis
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news